Detailed information for compound 71082

Basic information

Technical information
  • TDR Targets ID: 71082
  • Name: 2,4-diamino-5-chloro-N,N-diethylquinazoline-6 -sulfonamide
  • MW: 329.806 | Formula: C12H16ClN5O2S
  • H donors: 2 H acceptors: 4 LogP: 1.35 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(S(=O)(=O)c1ccc2c(c1Cl)c(N)nc(n2)N)CC
  • InChi: 1S/C12H16ClN5O2S/c1-3-18(4-2)21(19,20)8-6-5-7-9(10(8)13)11(14)17-12(15)16-7/h5-6H,3-4H2,1-2H3,(H4,14,15,16,17)
  • InChiKey: LXIZEVZFNIAAOK-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2,4-diamino-5-chloro-N,N-diethyl-quinazoline-6-sulfonamide
  • 2,4-diamino-5-chloro-N,N-diethyl-6-quinazolinesulfonamide
  • 2,4-bis(azanyl)-5-chloro-N,N-diethyl-quinazoline-6-sulfonamide
  • 92144-21-3
  • AIDS-195810
  • AIDS195810
  • 2,4-Diamino-5-chloro-quinazoline-6-sulfonic acid diethylamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase ABL1 0.0068 1 1
Schistosoma mansoni tyrosine kinase 0.0068 1 1
Brugia malayi Protein kinase domain containing protein 0.0068 1 1
Echinococcus multilocularis c src tyrosine kinase 0.0068 1 1
Schistosoma mansoni tyrosine kinase 0.0068 1 1
Brugia malayi Protein kinase domain containing protein 0.0068 1 1
Echinococcus granulosus c src tyrosine kinase 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Onchocerca volvulus 0.0068 1 1
Brugia malayi SH2 domain containing protein 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Fps85D 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Fyn 0.0068 1 1
Brugia malayi SRC-1 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase lyn lyn a protein tyrosine kinase lymphocyte specific protein tyrosine kinase 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Loa Loa (eye worm) TK/ABL protein kinase 0.0068 1 1
Entamoeba histolytica SH2-protein kinase domain containing protein 0.0068 1 0.5
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Srms 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase shark 0.0068 1 1
Brugia malayi Protein kinase domain containing protein 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Src42A 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Btk29A 0.0068 1 1
Onchocerca volvulus 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Echinococcus granulosus 3'partial|tyrosine protein kinase Fgr 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Blk 0.0068 1 1
Brugia malayi Protein kinase domain containing protein 0.0068 1 1
Echinococcus granulosus tyrosine kinase 0.0068 1 1
Echinococcus granulosus tyrosine kinase|tyrosine protein kinase Fyn 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0068 1 1
Echinococcus multilocularis tyrosine kinase 0.0068 1 1
Echinococcus granulosus proto oncogene tyrosine protein kinase LCK 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Echinococcus granulosus tyrosine kinase 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Btk29A 0.0068 1 1
Schistosoma mansoni tyrosine kinase 0.0068 1 1
Loa Loa (eye worm) TK protein kinase 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Brugia malayi SH2 domain containing protein 0.0068 1 1
Brugia malayi hypothetical protein 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Srms 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Src64B 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Fyn 0.0068 1 1
Onchocerca volvulus 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase lyn tyrosine protein kinase blk 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Schistosoma mansoni tyrosine kinase 0.0068 1 1
Brugia malayi Tyrosine-protein kinase abl-1 0.0068 1 1
Onchocerca volvulus 0.0068 1 1
Schistosoma mansoni proto-oncogene tyrosine-protein kinase src 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Blk 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Fps85D 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Fgr 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Src64B 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Abl 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Fyn 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase shark 0.0068 1 1
Onchocerca volvulus 0.0068 1 1
Onchocerca volvulus 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase Src42A 0.0068 1 1
Echinococcus multilocularis tyrosine protein kinase ABL1 0.0068 1 1
Brugia malayi protein-tyrosine kinase 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Lyn 0.0068 1 1
Loa Loa (eye worm) SRC-1 0.0068 1 1
Loa Loa (eye worm) hypothetical protein 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Schistosoma mansoni tyrosine kinase 0.0068 1 1
Echinococcus multilocularis proto oncogene tyrosine protein kinase LCK 0.0068 1 1
Echinococcus granulosus tyrosine protein kinase Fyn 0.0068 1 1
Loa Loa (eye worm) TK/FER protein kinase 0.0068 1 1
Schistosoma mansoni tyrosine kinase 0.0068 1 1

Activities

Activity type Activity value Assay description Source Reference
Delta MST (functional) = 2.3 day Change in mean survival of Plasmodium berghei infected mice following 40 mg/kg s.c. administration 72 hr after inoculation. ChEMBL. 6502605
Delta MST (functional) = 2.3 day Change in mean survival of Plasmodium berghei infected mice following 40 mg/kg s.c. administration 72 hr after inoculation. ChEMBL. 6502605
Delta MST (functional) = 4.3 day Change in mean survival of Plasmodium berghei infected mice following 80 mg/kg s.c. administration 72 hr after inoculation. ChEMBL. 6502605
Delta MST (functional) = 4.3 day Change in mean survival of Plasmodium berghei infected mice following 80 mg/kg s.c. administration 72 hr after inoculation. ChEMBL. 6502605
Delta MST (functional) = 5 day Antimalarial activity against drug-sensitive strain of Plasmodium berghei in mice after 72 hr (s.c.). The mean survival time of treated mice minus mean survival time of control mice at 640 mg/kg; value signifies the no. of toxic deaths occurring on days 2
-5 after infection
ChEMBL. 6502605
Delta MST (functional) = 5 day Antimalarial activity against drug-sensitive strain of Plasmodium berghei in mice after 72 hr (s.c.). The mean survival time of treated mice minus mean survival time of control mice at 640 mg/kg; value signifies the no. of toxic deaths occurring on days 2
-5 after infection
ChEMBL. 6502605
Delta MST (functional) = 14.9 day Antimalarial activity against drug-sensitive strain of Plasmodium berghei in mice after 72 hr (s.c.). The mean survival time of treated mice minus mean survival time of control mice at 160 mg/kg. ChEMBL. 6502605
Delta MST (functional) = 14.9 day Antimalarial activity against drug-sensitive strain of Plasmodium berghei in mice after 72 hr (s.c.). The mean survival time of treated mice minus mean survival time of control mice at 160 mg/kg. ChEMBL. 6502605
Delta MST (functional) = 18.9 day Antimalarial activity against drug-sensitive strain of Plasmodium berghei in mice after 72 hr (s.c.). The mean survival time of treated mice minus mean survival time of control mice at 320 mg/kg ChEMBL. 6502605
Delta MST (functional) = 18.9 day Antimalarial activity against drug-sensitive strain of Plasmodium berghei in mice after 72 hr (s.c.). The mean survival time of treated mice minus mean survival time of control mice at 320 mg/kg ChEMBL. 6502605
MIC (functional) < 0.25 ug ml-1 In vitro antibacterial activity against Streptococcus faecalis MGH-2. ChEMBL. 6502605
MIC (functional) = 10 ug ml-1 In vitro antibacterial acitivity against Streptococcus aureus U.C-76. ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 In vitro antibacterial activity against Streptococcus aureus S 18713. ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 In vitro against Pseudomonas aeruginosa 28. by gradient-plate test ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 Tested in vitro against Escherichia coli Vogel. by gradient-plate test ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 In vitro antibacterial activity against Shigella sonnei C-10. ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 In vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 Tested in vitro against Escherichia coli Vogel. by gradient-plate test ChEMBL. 6502605
MIC (functional) > 25 ug ml-1 In vitro antibacterial activity against Mycobacterium tuberculosis H37Rv. ChEMBL. 6502605

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.